Timeline of NIHR's response to COVID-19

Document: NIHR Clinical Research Networks High Level Objectives Outturn report 2021/22

Case Study: NIHR-funded researchers have developed a model called QCovid® that predicts the risk of people becoming seriously ill or dying from COVID-19. The model has been used to inform UK health policy, and its use by NHS Digital helped prioritise 820,000 people for vaccination.

Document: Institutions eligible to host applicants for NIHR Global Research Professorships

Document: A list of COVID-19 research projects funded through the Policy Research Programme's rapid COVID-19 funding process, or supported from existing funding to Policy Research Units.

Document: This document provides guidance for applicants submitting research proposals on Diagnostics, plus other topics to help and support individuals with Long COVID, for NIHR's 2021 funding call on Long COVID in non-hospitalised individuals.

Case Study: The NIHR is supporting REMAP-CAP; a nationally-prioritised study which aims to provide answers about the best treatment options for COVID-19 patients who develop pneumonia.

Case Study: The PRINCIPLE trial is the first study to test potential treatments for COVID-19 through GP surgeries and in the community.

Case Study: A landmark NIHR-funded and supported trial provides vital evidence to help resolve internationally conflicting guidance about respiratory support for severely ill COVID-19 patients. The results will reduce the need for mechanical ventilation and decrease the burden on critical care wards.

Case Study: Since 2016 the GenOMICC study has been researching what genetic factors affect whether people become severely ill from an infection. With the help of the NIHR, the study has rapidly ramped up to investigate coronavirus infection, studying genes from hundreds of very unwell patients to help understand what treatments might help tackle COVID-19.

Case Study: The REALIST trial is offering an innovative cell therapy treatment for patients with acute respiratory failure caused by COVID-19.

Case Study: The NIHR-supported RECOVERY trial is leading the way in identifying treatments for this new infectious disease.

Case Study: Healthcare workers from black, Asian and minority ethnic (BAME) backgrounds are putting their own health at risk to care for patients with COVID-19. But new research funded by the NIHR and UKRI, part of a multimillion package of new projects on COVID-19 and ethnicity, aims to understand that risk and provide evidence to inform the response to the pandemic.

Case Study: Phil was hospitalised with COVID-19 in early April 2020. Struggling to breathe, he was grateful to take part in the RECOVERY-RS trial. One year on, Phil has made a slow recovery and is now back at work, he told us his story.

Case Study: Following recruitment success in hospitals, Synairgen’s clinical trial of a new inhaled treatment for coronavirus infection turns its attention to COVID-19 patients in the community.

Case Study: A man who beat coronavirus and was among the first patients to enrol on the NIHR-supported RECOVERY trial, has spoken of how he wanted to “step up” to help with research into treatments for the disease.

Document: The latest information in relation to current and future NIHR awards, including any guidance published for NIHR Academy Members in relation to the impact of COVID-19.